Skip to Main Content

Author Details

Andrew D Yurochko
Louisiana State University
1987
81
38
PMIDPaper TitleJournal TitlePublished Year
36700640Virology under the Microscope-a Call for Rational Discourse.J Virol2023
37782657Proximity-dependent mapping of the HCMV US28 interactome identifies RhoGEF signaling as a requirement for efficient viral reactivation.PLoS Pathog2023
36709030Highly socially vulnerable communities exhibit disproportionately increased viral loads as measured in community wastewater.Environ Res2023
36700653Virology under the Microscope-a Call for Rational Discourse.mSphere2023
36700642Virology under the Microscope-a Call for Rational Discourse.mBio2023
36129424COVID-19 drive-through mass vaccination in Northwest Louisiana.J La Public Health Assoc2022
35862696Human Cytomegalovirus Manipulates Syntaxin 6 for Successful Trafficking and Subsequent Infection of Monocytes.J Virol2022
33177198CD34<sup>+</sup> Hematopoietic Progenitor Cell Subsets Exhibit Differential Ability To Maintain Human Cytomegalovirus Latency and Persistence.J Virol2021
33555590Using a Phosphoproteomic Screen to Profile Early Changes During HCMV Infection of Human Monocytes.Methods Mol Biol2021
33555584Collection and Isolation of CD14<sup>+</sup> Primary Human Monocytes Via Dual Density Gradient Centrifugation as a Model System to Study Human Cytomegalovirus Infection and Pathogenesis.Methods Mol Biol2021
33555579Overview of Human Cytomegalovirus Pathogenesis.Methods Mol Biol2021
34025614Human Cytomegalovirus Host Interactions: EGFR and Host Cell Signaling Is a Point of Convergence Between Viral Infection and Functional Changes in Infected Cells.Front Microbiol2021
32268565Human Cytomegalovirus Infection Suppresses CD34<sup>+</sup> Progenitor Cell Engraftment in Humanized Mice.Microorganisms2020
31866424Human Cytomegalovirus miRNAs Regulate TGF-β to Mediate Myelosuppression while Maintaining Viral Latency in CD34<sup>+</sup> Hematopoietic Progenitor Cells.Cell Host Microbe2020
32850474The Differentiation of Human Cytomegalovirus Infected-Monocytes Is Required for Viral Replication.Front Cell Infect Microbiol2020
32723814HCMV-induced signaling through gB-EGFR engagement is required for viral trafficking and nuclear translocation in primary human monocytes.Proc Natl Acad Sci U S A2020
30894498OR14I1 is a receptor for the human cytomegalovirus pentameric complex and defines viral epithelial cell tropism.Proc Natl Acad Sci U S A2019
31431555Human Cytomegalovirus US28 Ligand Binding Activity Is Required for Latency in CD34[+] Hematopoietic Progenitor Cells and Humanized NSG Mice.mBio2019
29691342Human Cytomegalovirus Encodes a Novel FLT3 Receptor Ligand Necessary for Hematopoietic Cell Differentiation and Viral Reactivation.mBio2018
30274264HCMV Infection and Apoptosis: How Do Monocytes Survive HCMV Infection?Viruses2018
27974567Human Cytomegalovirus Requires Epidermal Growth Factor Receptor Signaling To Enter and Initiate the Early Steps in the Establishment of Latency in CD34<sup>+</sup> Human Progenitor Cells.J Virol2017
28487392EphA2 Expression Regulates Inflammation and Fibroproliferative Remodeling in Atherosclerosis.Circulation2017
28420741New Mechanism by Which Human Cytomegalovirus MicroRNAs Negate the Proinflammatory Response to Infection.mBio2017
29021395Human Cytomegalovirus Utilizes a Nontraditional Signal Transducer and Activator of Transcription 1 Activation Cascade via Signaling through Epidermal Growth Factor Receptor and Integrins To Efficiently Promote the Motility, Differentiation, and Polarization of Infected Monocytes.J Virol2017
27432979Viral binding-induced signaling drives a unique and extended intracellular trafficking pattern during infection of primary monocytes.Proc Natl Acad Sci U S A2016
27501260Integrins as Herpesvirus Receptors and Mediators of the Host Signalosome.Annu Rev Virol2016
26676786Human Cytomegalovirus Promotes Survival of Infected Monocytes via a Distinct Temporal Regulation of Cellular Bcl-2 Family Proteins.J Virol2015
24639215Overview of human cytomegalovirus pathogenesis.Methods Mol Biol2014
24531335HCMV reprogramming of infected monocyte survival and differentiation: a Goldilocks phenomenon.Viruses2014
24639221Analysis of cytomegalovirus binding/entry-mediated events.Methods Mol Biol2014
23536674The ULb' region of the human cytomegalovirus genome confers an increased requirement for the viral protein kinase UL97.J Virol2013
23853586The HCMV gH/gL/UL128-131 complex triggers the specific cellular activation required for efficient viral internalization into target monocytes.PLoS Pathog2013
22837201Human cytomegalovirus stimulates monocyte-to-macrophage differentiation via the temporal regulation of caspase 3.J Virol2012
23242175A quantitative evaluation of cell migration by the phagokinetic track motility assay.J Vis Exp2012
22715139Human cytomegalovirus induction of a unique signalsome during viral entry into monocytes mediates distinct functional changes: a strategy for viral dissemination.J Leukoc Biol2012
21084488Human cytomegalovirus-regulated paxillin in monocytes links cellular pathogenic motility to the process of viral entry.J Virol2011
20173022PI3K-dependent upregulation of Mcl-1 by human cytomegalovirus is mediated by epidermal growth factor receptor and inhibits apoptosis in short-lived monocytes.J Immunol2010
20802174Cytomegalovirus infection leads to microvascular dysfunction and exacerbates hypercholesterolemia-induced responses.Am J Pathol2010
19427341NF-kappaB and phosphatidylinositol 3-kinase activity mediates the HCMV-induced atypical M1/M2 polarization of monocytes.Virus Res2009
20018733Activation of EGFR on monocytes is required for human cytomegalovirus entry and mediates cellular motility.Proc Natl Acad Sci U S A2009
18003728Transcriptome analysis of NF-kappaB- and phosphatidylinositol 3-kinase-regulated genes in human cytomegalovirus-infected monocytes.J Virol2008
18566437Transcriptome analysis reveals human cytomegalovirus reprograms monocyte differentiation toward an M1 macrophage.J Immunol2008
18637508Human cytomegalovirus modulation of signal transduction.Curr Top Microbiol Immunol2008
18375753Human CMV infection of endothelial cells induces an angiogenic response through viral binding to EGF receptor and beta1 and beta3 integrins.Proc Natl Acad Sci U S A2008
17507481Roles of phosphatidylinositol 3-kinase and NF-kappaB in human cytomegalovirus-mediated monocyte diapedesis and adhesion: strategy for viral persistence.J Virol2007
17344282The human cytomegalovirus virion possesses an activated casein kinase II that allows for the rapid phosphorylation of the inhibitor of NF-kappaB, IkappaBalpha.J Virol2007
16303162Prolonged activation of NF-kappaB by human cytomegalovirus promotes efficient viral replication and late gene expression.Virology2006
16987970Human cytomegalovirus (HCMV) infection of endothelial cells promotes naive monocyte extravasation and transfer of productive virus to enhance hematogenous dissemination of HCMV.J Virol2006
16103197Human cytomegalovirus IE1-72 activates ataxia telangiectasia mutated kinase and a p53/p21-mediated growth arrest response.J Virol2005
15107461HCMV activates PI(3)K in monocytes and promotes monocyte motility and transendothelial migration in a PI(3)K-dependent manner.J Leukoc Biol2004
  • 1 - 50 of 81

Recommended Authors

Icahn School of Medicine at Mount Sinai
Career Start Year 2009
Number of shared co-authors 5
University of Pennsylvania Perelman School of Medicine
Career Start Year 2006
Number of shared co-authors 0
National Institute of Allergy and Infectious Diseases.
Career Start Year 2006
Number of shared co-authors 0
Northwestern University Feinberg School of Medicine
Career Start Year 2004
Number of shared co-authors 0
Vaccine and Gene Therapy Institute, Oregon Health and Science University
Career Start Year 2000
Number of shared co-authors 10
University of Edinburgh
Career Start Year 1996
Number of shared co-authors 0
Cancer Research Institute, Central South University
Career Start Year 1995
Number of shared co-authors 1
University of California Berkeley
Career Start Year 1993
Number of shared co-authors 2
Icahn School of Medicine at Mount Sinai
Career Start Year 1993
Number of shared co-authors 7
West Virginia University School of Medicine
Career Start Year 1992
Number of shared co-authors 0
University of California los angeles
Career Start Year 1992
Number of shared co-authors 4
University of Utah
Career Start Year 1991
Number of shared co-authors 3
School of Public Health, University of California berkeley
Career Start Year 1990
Number of shared co-authors 0
Yale University
Career Start Year 1990
Number of shared co-authors 3
The Ohio State University, Wexner Medical Center
Career Start Year 1988
Number of shared co-authors 0
Institut Pasteur, Universite Paris Cite, CNRS UMR9
Career Start Year 1987
Number of shared co-authors 4
UK System Immunity Research Institute, Cardiff University
Career Start Year 1985
Number of shared co-authors 1
University of Vienna
Career Start Year 1985
Number of shared co-authors 0
Pathology Advanced Translational Research Unit, Emory University School of Medicine
Career Start Year 1981
Number of shared co-authors 2
Center for Computational and Integrative Biology, Massachusetts General Hospital
Career Start Year 1980
Number of shared co-authors 1
Vaccine and Gene Therapy Institute, Oregon Health & Science University
Career Start Year 1980
Number of shared co-authors 6
Seattle Children's Research Institute
Career Start Year 1979
Number of shared co-authors 4
Heersink School of Medicine, University of Alabama at Birmingham
Career Start Year 1979
Number of shared co-authors 7
University of Washington
Career Start Year 1978
Number of shared co-authors 6
Carver College of Medicine, University of Iowa
Career Start Year 1978
Number of shared co-authors 0
BioKien LLC
Career Start Year 1976
Number of shared co-authors 0
Center for Cancer Research, National Cancer Institute
Career Start Year 1975
Number of shared co-authors 1
Max von Pettenkofer-Institute, Ludwig-Maximilians-Universitat Munchen
Career Start Year 1973
Number of shared co-authors 0
Gladstone Institute of Virology, USA University of California san francisco
Career Start Year 1971
Number of shared co-authors 1
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Career Start Year 1969
Number of shared co-authors 0

Collaborators

Vaccine and Gene Therapy Institute, Oregon Health & Science University
Co-authored papers 13
Vaccine and Gene Therapy Institute, Oregon Health & Science University
Co-authored papers 8
Oregon Health and Science University
Co-authored papers 8
University of Arizona
Co-authored papers 7
Vaccine and Gene Therapy Institute, Oregon Health & Science University
Co-authored papers 6
Vaccine and Gene Therapy Institute, Oregon Health and Science University
Co-authored papers 6
Louisiana State University Health Sciences Center Shreveport
Co-authored papers 5
Co-authored papers 3
Co-authored papers 3
University of Washington Medical Center
Co-authored papers 3
NYU Grossman School of Medicine
Co-authored papers 3
UC Berkeley
Co-authored papers 3
Fred Hutchinson Cancer Research Center
Co-authored papers 3
Columbia University
Co-authored papers 3
University of Iowa
Co-authored papers 3
Icahn School of Medicine at Mount Sinai
Co-authored papers 3
Fred Hutchinson Cancer Center
Co-authored papers 3
Quantitative Biosciences Institute (QBI) Coronavirus Research Group (QCRG)
Co-authored papers 3
University of Utah School of Medicine
Co-authored papers 3
University of Utah School of Medicine
Co-authored papers 3
Co-authored papers 3
University of Michigan ann arbor
Co-authored papers 3
Duke University School of Medicine
Co-authored papers 3
Icahn School of Medicine at Mount Sinai
Co-authored papers 3
Co-authored papers 3
Rockefeller University
Co-authored papers 3
The Children's Hospital of Philadelphia
Co-authored papers 3
University of North Carolina at Chapel Hill.
Co-authored papers 3
Johns Hopkins Bloomberg School of Public Health
Co-authored papers 3
Icahn School of Medicine at Mount Sinai
Co-authored papers 3